.
MergerLinks Header Logo

New Deal


Announced

BIMI International Medical to acquire Chongqing Zhuoda Pharmaceutical.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

China

Domestic

Private

Friendly

pharmaceuticals supplier

Majority

Single Bidder

Acquisition

Pending

Pharmaceuticals

Synopsis

Edit

BIMI International Medical, a healthcare products and services provider, agreed to acquire Chongqing Zhuoda Pharmaceutical, a wholesale supplier of pharmaceuticals and medical equipment. Financial terms were not disclosed. “Zhuoda’s large customer base and operational resources will position us for what we expect to be an accelerated path to continued revenue growth and future profitability,” Tiewei Song, BIMI International CEO and President.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US